Impact of mitral regurgitation on long-term survival in patients with ischemic cardiomyopathy: Efficacy of combined mitral valve repair and revascularization

Heart and Vessels

Volumn 19, Issue 4, 2004, Pages 172-178

  Uchikawa, Shin Ichiro ^a   Ohtaki, Eiji ^b   Sumiyoshi, Tetsuya ^b   Hosoda, Saichi ^b   Kasegawa, Hitoshi ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAKAKIBARA HEART INSTITUTE   (Japan)

Author keywords

Coronary bypass surgery; Ischemic cardiomyopathy; Mitral regurgitation; Mitral valve repair; Survival

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; JAPAN; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 4344615492     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-004-0763-y     Document Type: Article

References (36)

1. Burch GE, Giles TD, Colcolough HL (1970) Ischemic cardiomyopathy. Am Heart J 79:291-292
2. Burch GE, Tsui CY, Harb JM (1972) Ischemic cardiomyopathy. Am Heart J 83:340-350
3. Burch GE, Tsui CY, Harb JM, Giles TD, Colcolough HL (1973) Ischemic cardiomyopathy. Am Heart J 86:276
4. Putz E, Vagelos R (2002) Clinical assessment in ischaemic cardiomyopathy. Nucl Med Commun 23:341-345
5. The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429-1435
6. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 325:293-302
7. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I (1975) Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy Br Heart J 37:1022-1036
8. Swedberg K (1993) Initial experience with beta blockers in dilated cardiomyopathy. Am J Cardiol 71:30C-38C
9. Fox RM, Nestico PF, Munley BJ, Hakki AH, Neumann D, Iskandrian AS (1986) Coronary artery cardiomyopathy. Hemodynamic and prognostic implications. Chest 89:352-356
10. Franciosa JA, Wilen M, Ziesche S, Cohn JN (1983) Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51:831-836
11. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G. Goldman S, Fletcher RD, Doherty J, Hughes CV, Carson P, Citron G. Shabetai R, Haakenson C (1991) A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325:303-310
12. Felker GM, Shaw LK, O'Connor CM (2002) A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 39:210-218
13. Villemot JP, Li Y, Schjoth H, Elfarra M, Carteaux JP, Dopff C, Hubert T, Mattei MF (2000) Advance cardiac failure. New surgical approaches (in French). Presse Med 29:1995-2003
14. Feldman MD, Beller GA (1990) Is secondary mitral regurgitation in congestive heart failure a marker of clinical importance? J Am Coll Cardiol 15:181-183
15. Bolling SF, Pagani FD, Deeb GM, Bach DS (1998) Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 115:381-388
16. Hachida M, Nonoyama M, Miyagishima M, Hoshi H, Iwade K, Matsuda N, Saito S, Hosoda S, Koyanagi H, Laks H (1997) Experience of patients with end-stage heart failure who underwent heart transplant at UCLA. Heart Vessels Suppl:34-36
17. Argenziano M, Michler RE, Rose EA (1997) Cardiac transplantation for endstage heart disease. Heart Vessels Suppl:23-27
18. Kleikamp G, Posival H, Minami K, El-Banayosy A, Korfer R (1997) Ischemic cardiomyopathy - revascularization vs. transplantation Eur J Cardiothorac Surg 11 Suppl:S1-S4
19. Kron IL, Flanagan TL, Blackbourne LH, Schroeder RA, Nolan SP (1989) Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg 210:348-354
20. Chen FY, Adams DH, Aranki SF, Collins JJ Jr, Couper GS. Rizzo RJ. Cohn LH (1998) Millar valve repair in cardiomyopathy. Circulation 98:II124-II127
21. Gangemi JJ, Tribble CG, Ross SD, McPherson JA, Kern JA, Kron IL (2000) Dose the additive risk of mitral valve repair in patients with ischemic cardiomypathy prohibit surgical intervention? Ann Surg 231:710-714
22. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M (1997) Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 96:793-800
23. Elefteriades J, Edwards R (2002) Coronary bypass in left heart failure. Semin Thorac Cardiovasc Surg 14:125-132
24. Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJ (1999) Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 100:1298-1304
25. Tjan TD, Kondruweit M, Scheld HH, Roeder N, Borggrefe M, Schmidt C, Schober O, Deng MC (2000) The bad ventricle - revascularization versus transplantation. Thorac Cardiovasc Surg 48:9-14
26. Blitz A, Laks H (1996) The role of coronary revascularization in the management of heart failure: identification of candidates and review of results. Curr Opin Cardiol 11:276-290
27. Dreyfus GD, Duboc D, Blasco A, Vigoni F, Dubois C, Brodaty D, de Lentdecker P, Bachet J, Goudot B, Guilmet D (1994) Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg 57:1402-1408
28. Dreyfus GD (1998) Alternative surgical options to heart transplantation (in French). Arch Mal Coeur Vaiss 91:1413-1422
29. Langenburg SE, Buchanan SA, Blackbourne LH, Scheri RP, Sinclair KN, Martinez J, Spotnitz WD, Tribble CG, Kron IL (1995) Predicting survival after coronary revascularization for ischemic cardiomyopathy. Am Thorac Surg 60:1193-1197
30. Gureev SV, Kasakov EN, Kormer AY, Ostroumov EN, Shumakov VI (1999) Surgical treatment of patients with ischemic cardiomyopathy: the significance of right ventricular function. Heart Surg Forum 2:330-337
31. Beller GA (1997) Selecting patients with ischemic cardiomyopathy for medical treatment, revascularization, or heart transplantation. J Nucl Cardiol 4:S152-S157
32. Menicanti E, Di Donato M, Frigiola A, Buckberg G, Santambrogio C, Ranucci M, Santo D (2002) Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg 123:1041-1050
33. Bitran D, Merin O, Fisher J, Shapira N. Klutstein MW. Silberman S (2000) Mitral valve repair in ischemic cardiomyopathy with severe left ventricular dyfunction (in Hebrew). Harefuah 138:820-822, 911
34. Bitran D. Merin O, Klutstein MW, Od-Allah S, Shapira N, Silberman S (2001) Mitral valve repair in severe ischemic cardiomyopathy. J Card Surg 16:79-82
35. Bolling SF (2002) Mitral reconstruction in cardiomyopathy. J Heart Valve Dis 11 Suppl 1:S26-S31
36. Dreyfus GD, Milaiheanu S (2000) Mitral valve repair in cardiomyopathy. J Heart Lung Transplant 19:S73-S76